Research output per year
Research output per year
Fingerprint
Dive into the research topics where Jinseok Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment
Dimopoulos, M. A., Mikhael, J., Terpos, E., Leleu, X., Moreau, P., Bladé, J., Kim, J. S., Stockerl-Goldstein, K. & Richardson, P. G., 2022 Apr, In: Therapeutic Advances in Hematology. 13Research output: Contribution to journal › Review article › peer-review
Open Access1 Citation (Scopus) -
Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)
The Korean Multiple Myeloma Working Party (KMMWP), 2022 Jul, In: International Journal of Hematology. 116, 1, p. 110-121 12 p.Research output: Contribution to journal › Article › peer-review
-
Corrigendum to “P-137: ITHACA, A Randomized Multicenter Phase 3 Study of Isatuximab in Combination With Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma: Safety Run-in Preliminary Results” [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S109- S110] (Clinical Lymphoma, Myeloma and Leukemia (2021) 21(S2) (S1–S189), (S2152265021X00122))
Ghobrial, I. M., Rodríguez-Otero, P., Koh, Y., Martínez-López, J., Parmar, G., Prince, M., Quach, H., de la Rubia, J., Hermansen, E., Hungria, V., Kalayoglu Besisik, S., Kim, J. S., Leleu, X., Peceliunas, V., Schjesvold, F., Dubin, F., Devisme, C., Lepine, L., Macé, S., Oprea, C., & 1 others, 2022 Jul, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 7, p. 545 1 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
Ha, J., Cho, H., Lee, T. G., Shin, S., Chung, H., Jang, J. E., Kim, S. J., Cheong, J. W., Lee, S. T., Kim, J. S. & Choi, J. R., 2022 Dec, In: Scientific reports. 12, 1, 8287.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study
Kwak, L. W., Sancho, J. M., Cho, S. G., Nakazawa, H., Suzumiya, J., Tumyan, G., Kim, J. S., Menne, T., Mariz, J., Ilyin, N., Jurczak, W., Lopez Martinez, A., Samoilova, O., Zhavrid, E., Yañez Ruiz, E., Trneny, M., Popplewell, L., Ogura, M., Kim, W. S., Lee, S. J., & 3 others, 2022 Feb, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 2, p. 89-97 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus)
Press/Media
-
Severance Healthcare: TDF administration confirms hepatitis B preventive effect in patients with malignant lymphoma
23/3/17
1 item of Media coverage
Press/Media: Press / Media
-
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma
18/10/2
1 item of Media coverage
Press/Media: Press / Media
-
Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia
18/10/2
1 item of Media coverage
Press/Media: Press / Media
-
-
Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma; CITADEL
18/10/2
1 item of Media coverage
Press/Media: Press / Media